Seven-year Trends in Visual Acuity at First Presentation in Patients with Neovascular AMD.
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Australia; Ophthalmology, Department of Surgery, University of Melbourne, Australia. Electronic address: hessom.razavi@health.wa.gov.au.
Hessom
H
Razavi
Save Sight Institute, Sydney Medical School, The University of Sydney, Australia.
Richard
R
Walton
Save Sight Institute, Sydney Medical School, The University of Sydney, Australia.
Mark
M
Gillies
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Australia; Ophthalmology, Department of Surgery, University of Melbourne, Australia.
Robyn
R
Guymer
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D058449:Intravitreal Injections; D011379:Prognosis; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014792:Visual Acuity / Q000502:physiology*; D057135:Wet Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology
D020533:Angiogenesis Inhibitors; D042461:Vascular Endothelial Growth Factor A